Mesoblast Limited (ASX:MSB)
2.220
-0.070 (-3.06%)
Nov 7, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
323.85K AUD
Profits / Employee
-1.92M AUD
Market Cap
2.85B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ramsay Health Care | 90,000 |
| Sonic Healthcare | 45,000 |
| CSL Limited | 29,904 |
| Ansell | 15,000 |
| Regis Healthcare | 12,000 |
| Cochlear | 5,500 |
| Nanosonics | 470 |
| Telix Pharmaceuticals | 234 |
Mesoblast News
- 2 days ago - Mesoblast Breaks Below 200-Day Moving Average - Notable for MESO - Nasdaq
- 3 days ago - This Casino Stock Got Dealt A Good Hand - Benzinga
- 4 days ago - Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation - GlobeNewsWire
- 20 days ago - Mesoblast Q1 Revenue From Cell Therapy Products Surges - Nasdaq
- 20 days ago - Ryoncil® Net Revenues Increase 69% in Second Quarter Post Launch - GlobeNewsWire
- 4 weeks ago - Mesoblast: Back Pain And Heart Failure Remain Option Value, Not Base Case - Seeking Alpha
- 4 weeks ago - Mesoblast (MESO) Reports Strong Revenue Growth for Ryoncil Sales - GuruFocus
- 4 weeks ago - Mesoblast (MEOBF) Sees Significant Revenue Growth in Recent Quarter - GuruFocus